REGN insider trading
Regeneron Pharmaceuticals, Inc. · end-of-day data as of Oct 16, 2026
Regeneron Pharmaceuticals, Inc.
$790.74+20.7%
Buy · 29 analystsPT $859.53 +8.7%
In the last 12 months REGN insiders made 0 open-market purchases and 17 sales worth $16.11M, as reported on SEC Form 4. The latest: MURPHY ANDREW J (officer: Co-Chief Scientific Officer) sold 4,147 shares at $772.70 on Oct 14, 2026.
Last 90 days
- Insiders-$6.51M
Transactions
Open-market buys $0 · sells $16.11M over the last 365 days (0 buys, 17 sells).
| Oct 14, 2026 | MURPHY ANDREW J | Sell | 4,147 | $772.70 | $3.2M |
| Oct 13, 2026 | MURPHY ANDREW J | Other | 46,853 | $484.15 | $22.68M |
| Sep 3, 2026 | McCourt Marion | Sell | 1,131 | $857.39 | $970K |
| Sep 2, 2026 | Guarini Kathryn | Other | 800 | $719.37 | $575K |
| Sep 2, 2026 | Guarini Kathryn | Sell | 400 | $850.00 | $340K |
| Sep 2, 2026 | McCourt Marion | Sell | 1,215 | $850.00 | $1.03M |
| Aug 19, 2026 | LAROSA JOSEPH J | Other | 33,583 | $502.30 | $16.87M |
| Aug 18, 2026 | Fenimore Christopher R. | Other | 17,165 | $497.54 | $8.54M |
| Aug 10, 2026 | Guarini Kathryn | Other | 800 | $719.37 | $575K |
| Aug 10, 2026 | Guarini Kathryn | Sell | 400 | $800.00 | $320K |
| Aug 10, 2026 | Zoghbi Huda Y | Sell | 800 | $800.00 | $640K |
| Aug 10, 2026 | Zoghbi Huda Y | Other | 1,600 | $376.69 | $603K |
| Jul 2, 2026 | RYAN ARTHUR F | Sell | 200 | $650.15 | $130K |
| May 1, 2026 | RYAN ARTHUR F | Sell | 100 | $705.24 | $70.52K |
| Apr 1, 2026 | RYAN ARTHUR F | Sell | 100 | $777.27 | $77.73K |
| Mar 2, 2026 | RYAN ARTHUR F | Sell | 100 | $785.50 | $78.55K |
| Feb 19, 2026 | Zoghbi Huda Y | Other | 3,276 | $376.69 | $1.23M |
| Feb 19, 2026 | Zoghbi Huda Y | Sell | 1,638 | $781.33 | $1.28M |
| Feb 9, 2026 | Pitofsky Jason | Sell | 2,036 | $778.52 | $1.59M |
| Feb 9, 2026 | Pitofsky Jason | Other | 2,000 | $492.00 | $984K |
Source: SEC Form 4 filings. "Other" covers awards, option exercises and gifts.